Delivery Order SPE2DB22D2007-SPE2DB24FH9NL
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,504.30 delivery order is for 4,558,371,656 units of Atomoxetine HCL 40 mg capsules. The award is part of a broader Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,561,888,754 units of Atomoxetine HCL 18 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The Delivery Order contract, valued at $4,381.89, has a firm fixed price and an ultimate completion date of August 22, 2023. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,095.38 firm fixed-price delivery order is for the supply of 4,565,504,831 units of the prescription medication Atomoxetine HCL 60 mg capsules. The contract has an ultimate completion date of August 20, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA). The $1,134.63 firm fixed-price delivery order is for the supply of 4,566,817,731 units of the drug Atomoxetine HCL 25 mg capsules. The contract has an ultimate completion date of January 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award, valued at $9,150.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of 4,568,003,079 units of the medication Atomoxetine 40mg in 30-count packaging. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Atomoxetine HCL 18 mg capsules. The award, with a ceiling value of $1,265.40, is structured as a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a maximum value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,080.97, is a delivery order contract for the supply of 4566861402 - Atomoxetine HCL 40 MG Capsule 30S. The contract has a completion date of January 8, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,603.09 firm fixed-price delivery order is for the provision of 4,563,867,448 units of the medication Atomoxetine HCL 25 mg capsules. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Atomoxetine HCL 40 mg capsules. The firm-fixed-price contract, which does not have a set-aside designation, has a ceiling value of $1,891.58 and an ultimate completion date of September 30, 2024. AmerisourceBergen, through its Corporate Office Division, is a key contractor for providing a wide range of prescription medications,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,332.93 firm fixed-price delivery order is for the supply of 4566771107 - Atomoxetine HCL 40 mg capsules in quantities of 30s. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH9NLDelivery Order
This federal contract award, valued at $1,699.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of Atomoxetine HCL 40 mg capsules. The contract has a completion date of February 13, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 2/12/24 |